Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Neutral Rating on Intel (INTC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Regeneron Pharma (REGN)
-
Cantor Fitzgerald Reiterates Neutral Rating on CommVault Systems (CVLT)
-
Tenable (TENB) PT Lowered to $42 at Cantor Fitzgerald
-
Seagate Technology (STX) PT Raised to $110 at Cantor Fitzgerald
-
Booking Holdings (BKNG) PT Raised to $4,440 at Cantor Fitzgerald
-
Snap Inc (SNAP) PT Lowered to $7 at Cantor Fitzgerald
-
Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 202
-
USA Rare Earth (USAR) Announces $75M PIPE Investment
-
USA Rare Earth Announces $75 Million PIPE Investment
-
Spotify (SPOT) PT Raised to $610 at Cantor Fitzgerald
-
BTIG Announces Strategic Leadership Appointments in Healthcare Investment Banking, Hires Karen Flaherty to Bolster MedTech Team
-
Cantor Fitzgerald positive on GovTech & Space after ~150b spend announced
-
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor
-
Cantor Fitzgerald Reiterates Overweight Rating on Rezolve AI Ltd. (RZLV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Teradyne (TER)
-
Cantor Fitzgerald Reiterates Overweight Rating on NXP Semiconductors NV (NXPI)
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Madrigal Pharmaceuticals (MDGL)
-
Inflection Point Acquisition Corp. III Announces Closing of $253,000,000 Million Initial Public Offering
-
Cantor Fitzgerald Starts BioCryst Pharma (BCRX) at Overweight
-
Cantor Fitzgerald Starts WAVE Life Sciences (WVE) at Overweight
-
Cantor Fitzgerald Starts Viking Therapeutic (VKTX) at Overweight
-
Cantor Fitzgerald Starts ProQR Therapeutics N.V. (PRQR) at Overweight
-
Cantor Fitzgerald Starts Editas Medicine (ATXS) at Overweight
-
Cantor Fitzgerald Starts Apellis Pharmaceuticals (APLS) at Overweight
-
Cantor Fitzgerald Starts Inflarx NV (IFRX) at Overweight
-
Cantor Fitzgerald Starts Korro Bio Inc. (KRRO) at Overweight
-
Western Digital Corp. (WDC) PT Lowered to $50 at Cantor Fitzgerald
-
Seagate Technology (STX) PT Lowered to $100 at Cantor Fitzgerald
-
Teradyne (TER) PT Lowered to $90 at Cantor Fitzgerald
-
NXP Semiconductors NV (NXPI) PT Lowered to $225 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
-
Cantor Fitzgerald Reiterates Overweight Rating on CG Oncology (CGON)
-
Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
New Providence Acquisition Corp. III Completes $300,150,000 Initial Public Offering
-
Cantor Equity shares rally as retail investors cheer crypto venture
-
Graphene Manufacturing Group Provides Quarterly ATM Sales Update
-
Semler Scientific (SMLR) Announces Updated BTC & ATM Activity
-
Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 111 BTC; Now Holds 3,303 BTC; YTD BTC Yield of 23.5%
-
Alphabet (GOOGL) PT Raised to $171 at Cantor Fitzgerald
-
Inflection Point Acquisition Corp. III Announces Pricing of $220 Million Initial Public Offering
-
Orchid Island Capital Announces First Quarter 2025 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Molina Healthcare (MOH)
-
Cantor Fitzgerald Reiterates Overweight Rating on CACI International (CACI)
-
Cantor Fitzgerald Reiterates Neutral Rating on Checkpoint Software (CHKP)
-
Cantor Fitzgerald Reiterates Overweight Rating on Lam Research (LRCX)

